Advertisement

Related Videos

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Advertisement

Advertisement




Feb
19
Today In Oncology
Genetics Pioneer Zsofia Stadler to Lead JCO Precision Oncology
Does Diabetes Increase Pancreatic Cystic Neoplasm Risk
Topline PFS Results From BREAKWATER in mCRC Newly Announced
Adding Encorafenib and Cetuximab to FOLFIRI Shows Benefit in BRAF-Mutant Colorectal Cancer
Pleurectomy Decortication Safe in Select Patients With Pleural Mesothelioma
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo